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Aortic Valve Replacement
for Low-Flow/Low-Gradient Aortic Stenosis
Operative Risk Stratification and
Long-Term Outcome: A European Multicenter Study
Franck Levy, MD,* Marcel Laurent, MD,† Jean Luc Monin, MD,‡ Jean Michel Maillet, MD,§
Agnès Pasquet, MD, Thierry Le Tourneau, MD,¶ Hélène Petit-Eisenmann, MD,# Mauro Gori, MD,**
Yannick Jobic, MD,†† Fabrice Bauer, MD,‡‡ Christophe Chauvel, MD,§§ Alain Leguerrier, MD, PHD,†
Christophe Tribouilloy, MD, PHD, FACC*
Amiens, Rennes, Créteil, Saint Denis, Lille, Strasbourg, Brest, Rouen, and Bordeaux, France;
Brussels, Belgium; and Bergamo, Italy
Objectives We evaluated a large multicenter series of patients operated on for low-flow/low-gradient aortic stenosis (LF/
LGAS) to stratify the operative risk, assess whether perioperative mortality has decreased over recent years, and
analyze the post-operative outcome.
Background Although LF/LGAS is classically associated with a high operative risk, few data are available concerning the re-
sults of surgery in this setting.
Methods A total of 217 consecutive patients (168 men, 77%) with severe aortic stenosis (area 1 cm2), low ejection frac-
tion (EF) (35%), and low mean gradient (MG) (30 mm Hg) who underwent aortic valve replacement (AVR)
between 1990 and 2005 were included.
Results Perioperative mortality was 16% and decreased dramatically from 20% in the 1990 to 1999 period to 10% in the
2000 to 2005 period. Higher European System for Cardiac Operative Risk Evaluation score (EuroSCORE), very low MG
and EF, New York Heart Association functional class III or IV, history of congestive heart failure, and multivessel coro-
nary artery disease (MVD) were associated with perioperative mortality. On multivariate analysis, very low pre-
operative MG and MVD were predictors of excess perioperative mortality. In the subgroup of patients with dobutamine
stress echocardiography, the absence of contractile reserve was a strong predictor of perioperative mortality. Overall
5-year survival rate was 49  4%. Lower MG, higher EuroSCORE, prior atrial fibrillation, and MVD were identified as
independent predictors of overall long-term mortality.
Conclusions In view of the very poor prognosis of unoperated patients, the current operative risk, and the long-term outcome
after surgery, AVR is the treatment of choice in the majority of cases of LF/LGAS. (J Am Coll Cardiol 2008;51:
1466–72) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.10.067p
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batients with severe aortic stenosis (AS) and reduced left
entricular ejection fraction (LVEF) have a poor prognosis
ith conservative treatment. In addition, aortic valve re-
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rance; and the §§Department of Cardiology, Clinique Saint-Augustin, Bordeaux, France.o
Manuscript received June 21, 2007; revised manuscript received October 24, 2007,
ccepted October 29, 2007.lacement (AVR) in these patients is associated with a
elatively high operative mortality (1,2). Operative risk is
articularly high in patients with low pre-operative trans-
alvular mean gradient (MG) (3). Although American
ollege of Cardiology/American Heart Association guide-
ines recently defined low-gradient AS as severe AS with an
G30 mmHg, low flow, and left ventricular dysfunction
4), the definition of “low-gradient” AS has varied from
tudy to study (5). Few data are available concerning the
esults of surgery in patients with severe AS and a MG30
m Hg (3,6,7). Most published studies (5,8–10) have
ncluded patients with mean aortic transvalvular gradient
etween 30 and 40 mm Hg, who are known to be at lower
perative risk (5). We therefore evaluated a large series of
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April 15, 2008:1466–72 Prognosis in Low-Gradient ASonsecutive patients operated for AS with low gradient
30 mm Hg) to stratify the operative risk, assess whether
he perioperative mortality decreased over the recent period,
nalyze the post-operative outcome, and determine the
redictors of long-term mortality.
ethods
he study population consisted of 217 consecutive patients,
68 men (77%) and 49 women (23%), with symptomatic
evere aortic stenosis (area1 cm2), low ejection fraction (EF)
35%), and low MG (30 mm Hg) who underwent aortic
alve replacement between 1990 and 2005. Eleven centers
ere involved in this European study (Amiens, France; Ber-
amo, Italy; Bordeaux, France; Brest, France; Brussels, Bel-
ium; Créteil, France; Lille, France; Rennes, France; Rouen,
rance; Saint Denis, France; and Strasbourg, France). Pa-
ients with significant aortic regurgitation, severe mitral
egurgitation, or associated mitral surgery were excluded.
linical, laboratory, and echocardiographic data are pre-
ented in Table 1. Pre-operative atrial fibrillation was
efined as permanent or paroxystic atrial fibrillation
efore surgery. Patients with unstable hemodynamic
tatus operated during the 4 days following admission
ere considered emergency cases. Clinical follow-up was
ompleted in all patients, with a mean follow-up of 31 
1 months.
chocardiography. Complete pre-operative echocardiog-
aphy, including aortic valve area assessment, was performed
n all patients (11). Left ventricular ejection fraction was
stimated according to Simpson’s rule (12) in 86% of
atients and visually (13) in 14% of patients. Dobutamine
tress echocardiography (DSE) was performed in 38% of
atients (83 of 217) according to a previously described
tandard protocol (9,10). Contractile reserve was defined by
n increase in stroke volume of 20% compared with the
aseline value (9,10,14). All patients with contractile reserve
ad fixed AS, defined as an increase in valve area 0.3 cm2
ith a final valve area 1 cm2 on DSE (9,10,14). Use of
SE for each patient was left to the discretion of the
eferring physicians in each center.
oronary angiography. Pre-operative coronary angiogra-
hy was performed in 98% of patients. Reduction of the
ormal diameter 50% was considered to define significant
oronary artery stenosis in the left main coronary artery. A
utoff value of 70% was used for the right coronary, left
nterior descending, and circumflex arteries. Multivessel
oronary artery disease (MVD) was defined as significant
tenoses on 2 or more vessels.
alculation of the European System for Cardiac Operative
isk Evaluation (EuroSCORE). The standard Euro-
CORE was calculated retrospectively for each patient
sing the calculator available online (15). Integrated risk
actors in the EuroSCORE are patient-related, cardiac, and
peration-related factors. Patient-related factors are age
ver 60 years, female gender, chronic pulmonary disease, Txtracardiac arterial disease, neu-
ologic dysfunction, previous car-
iac surgery, serum creatinine
200 mol/l, active endocardi-
is, and critical pre-operative
tate. Cardiac factors are unstable
ngina, reduced LVEF, recent
yocardial infarction, and pul-
onary systolic pressure 60
m Hg. Operation-related fac-
ors are emergency, other than
solated coronary surgery; tho-
acic aorta surgery; and surgery
or post-infarct septal rupture.
ortality and clinical follow-
p. Operative mortality was de-
ned as death within 30 days
fter AVR (3,10). Overall mor-
ality combined operative mor-
ality and late mortality. The end
oints evaluated at follow-up
ere survival and New York
eart Association (NYHA) func-
ional status. The NYHA func-
ional status after surgery, obtained
y direct patient examination or
elephone interview, was available in 85% (156 of 183) of the
atients who survived after AVR. Ejection fraction after AVR
as evaluated by the referring physician and was available in
6% of the surviving patients after AVR.
tatistical analysis. Continuous variables are expressed as
ean  SD, and categorical variables are expressed as
ercentages. Comparisons between groups were performed
sing the chi-square test or the Fisher exact test (when
eeded) to analyze differences in categorical variables. The
tudent t test or Wilcoxon rank-sum test were used as
ppropriate for continuous variables. Changes in NYHA
unctional status over time were compared using the Mc-
emar’s test. The optimal cutoff value of EuroSCORE to
redict operative mortality was determined by receiver-
perating characteristic curve analysis. On multivariate
nalysis, the Cox proportional hazard model was used to
tudy survival after AVR, and logistic regression was used to
nalyze operative mortality. All multivariate analyses were
erformed with p  0.05 as the limit on univariate analysis
or entering or removing variables. Survival curves were
lotted using the Kaplan-Meier method and differences
ere tested with the log-rank test. A p value 0.05 was
onsidered statistically significant.
esults
re-operative clinical, echocardiographic, and angiographic
ata from the 217 patients of the study are presented in
Abbreviations
and Acronyms
AS  aortic stenosis
AVR  aortic valve
replacement
CAD  coronary artery
disease
DSE  dobutamine stress
echocardiography
EF  ejection fraction
EuroSCORE  European
System for Cardiac
Operative Risk Evaluation
HR  hazard ratio
LF/LGAS  low-flow/low-
gradient aortic stenosis
LVEF  left ventricular
ejection fraction
MG  mean gradient
MVD  multivessel
coronary artery disease
NYHA  New York Heart
Association
OR  odds ratioable 1. Pre-operatively, 79% (123 of 156) of patients were
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Prognosis in Low-Gradient AS April 15, 2008:1466–72lassified as NYHA functional class III or IV, compared
ith 16% (25 of 156) after AVR (p  0.0001). The
VEF significantly improved from 28  5% pre-operatively
o 41  13% after AVR (p  0.0001).
perative mortality. In the overall series, perioperative
ortality was 16% (n  34), related to cardiogenic shock in
9% (n  27), septic shock in 9% (n  3), stroke in 3%
n 1), respiratory failure in 3% (n 1), multiorgan failure
n 3% (n  1), and critical limb ischemia in 3% (n  1).
onger cardiopulmonary bypass time and cross-clamp time
ere also associated with perioperative mortality. On uni-
ariate analysis, higher EuroSCORE, very lowMG and EF,
YHA functional class III or IV, history of congestive heart
ailure, and MVD were associated with perioperative mor-
ality (Table 1). These parameters were entered in the
ultivariate model for perioperative mortality. Pre-operative
G (odds ratio [OR] 0.89; 95% confidence interval [CI] 0.83
o 0.96; p  0.02) and presence of MVD (OR 2.2; 95% CI
.02 to 5.02; p  0.045) were identified as independent
redictors of perioperative mortality. Operative mortality was
0% in patients with a pre-operative MG 20 mm Hg and
VD, compared with 10% in patients without coronary artery
linical Characteristics of the Population and Predictors oferioperative Mo tal ty on Univariate Analysis in the 217 Patients
Table 1 Clinical Characteristics of the Population and PredictoPerioperative Mortality on Univariate Analysis in the 2
Total Pop
(n  2
Age (yrs) 71
Men 168 (7
Stable angina 37 (1
Pre-operative NYHA functional class III to IV† 180 (8
History of congestive heart failure 195 (9
EuroSCORE (standard) 8.9
EuroSCORE 10 59 (2
Diabetes mellitus 54 (2
Atrial fibrillation 58 (2
Prior myocardial infarction 49 (2
Multivessel coronary artery disease 61 (2
Aortic valve area (cm2) 0.72
Left ventricular ejection fraction (%) 28
Mean transvalvular gradient (mm Hg) 25
Mean transvalvular gradient 20 mm Hg 36 (1
Systolic pulmonary artery pressure (mm Hg) 47
Left bundle-branch block 62 (2
Contractile reserve on dobutamine stress echocardiography* 62/83 (7
Aortic prosthesis size (mm) 23
Aortic prosthesis type
Mechanical 79 (3
Bioprosthesis 137 (6
Aortic valve repair 1 (0
Coronary artery bypass graft 74 (3
Emergency AVR 27 (1
Cardiopulmonary bypass time (min) (n  186) 105
Cross-clamp time (min) (n  187) 73
Dobutamine stress echocardiography was performed in 83 patients in the study; †pre-operative
AVR  aortic valve replacement; EuroSCORE  European System for Cardiac Operative Risk Evisease (CAD) and with pre-operativeMG20 mmHg (p g.02). Perioperative mortality was 25% when the Euro-
CORE was 10, compared with 12% when the Euro-
CORE was 10 (p  0.02). Perioperative mortality was
5.5% in the subgroup of patients who underwent pre-
perative DSE (n  83) and reached 38% in patients
ithout contractile reserve on DSE, compared with 8% in
atients with contractile reserve. In the subgroup of patients
ho had DSE, multivariate analysis identified lack of
ontractile reserve (OR 4.4; 95% CI 1.1 to 17.5; p  0.03)
nd MVD (OR 6; 95% CI 1.5 to 24; p  0.01) as
ndependent predictors of perioperative mortality. Patients
ho had DSE were more frequently women (32% vs. 16%;
 0.006), had a lower rate of paroxysmal or permanent
trial fibrillation (18% vs. 32%; p  0.023), had lower
re-operative EF (26  6 vs. 29  6; p  0.002), and were
ess often operated in emergency (6% vs. 16%; p  0.024).
Baseline characteristics of patients operated in the 1990
o 1999 era (n 112) and in the 2000 to 2005 era (n 105)
re summarized in Table 2. Operative mortality was lower
n the recent era (10% vs. 20%, p  0.04). No significant
ifferences were observed between the 2 groups for most
re-operative parameters. However, in the recent era, emer-
Study
tients in the Study
n
Perioperative Period
p ValueAlive* (n  183) Dead* (n  34)
71 9 72 6 0.29
139 (76%) 29 (85%) 0.27
33 (18%) 4 (12%) 0.46
147 (80%) 33 (97%) 0.013
161 (88%) 34 (100%) 0.03
8.7 2.6 9.9 3.1 0.02
44 (24%) 15 (44%) 0.02
44 (24%) 10 (29%) 0.48
46 (25%) 12 (35%) 0.22
42 (23%) 7 (21%) 0.76
46 (25%) 15 (44%) 0.01
0.72 0.15 0.71 0.17 0.62
28 5 26 6 0.03
26 5 22 6 0.007
26 (14%) 10 (29%) 0.03
47 14 47 15 0.97
54 (30%) 8 (24%) 0.66
57/70 (81%) 5/13 (38%) 0.001
23 2 24 2 0.12
68 (37%) 11 (32%)
114 (62.5%) 23 (68%) 0.78
1 (0.5%) 0
58 (32%) 16 (47%) 0.08
21 (11%) 6 (18%) 0.32
97 38 151 101 0.011
69 30 92 47 0.024
unctional status under medical treatment.
n; NYHA  New York Heart Association.in the
rs of
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April 15, 2008:1466–72 Prognosis in Low-Gradient ASnfarction and atrial fibrillation tended to be more frequent,
nd cardiopulmonary bypass time tended to be shorter.
erioperative deaths related to cardiogenic shock were more
requent in the past era than in the current era (91% vs. 54%,
 0.024).
Comparison of Patients Operated in the 1990 toEra
Table 2 Comparison of Patients Operated in
1
Age (yrs)
Men
Stable angina
Pre-operative NYHA functional class III to IV†
History of congestive heart failure
EuroSCORE
Diabetes
Atrial fibrillation
Prior myocardial infarction
Multivessel coronary artery disease
Aortic valve area (cm2)
Left ventricular ejection fraction (%)
Mean transvalvular gradient (mm Hg)
Mean transvalvular gradient 20 mm Hg
Systolic pulmonary artery pressure (mm Hg)
Left bundle-branch block
Aortic prosthesis size (mm)
Aortic prosthesis type
Mechanical
Bioprosthesis
Aortic valve repair
Dobutamine stress hemodynamics*
CABG
Emergency AVR
Cardiopulmonary bypass time (min) (n  186)
Cross-clamp time (min) (n  187)
Cardiac shock as a cause of perioperative death
Perioperative mortality
*Dobutamine stress echocardiography was performed in 83 patients i
CABG  coronary artery bypass graft; other abbreviations as in Tabt
Figure 1 5-Year Overall Survival Curve in the Total Populationurvival after AVR. The overall 5-year survival rate in the
otal population was 49  4% (Fig. 1). On univariate
nalysis, overall survival was significantly lower in patients
ith higher EuroSCORE, diabetes, prior AF, pre-operative
G 20 mm Hg, and MVD (Table 3, Fig. 2). These
arameters were entered in the multivariate model for overall
-year survival. Pre-operative MG (hazard ratio [HR] 0.95;
5% CI 0.91 to 0.99, p  0.015), EuroSCORE (HR 1.13;
5% CI 1.04 to 1.23, p  0.004), prior atrial fibrillation
HR 1.75; 95% CI 1.07 to 2.85; p  0.025), and MVD
HR 1.85; 95% CI 1.05 to 2.72; p  0.03) were identified
s independent predictors of overall mortality.
Fifty-four patients died during follow up. Late deaths
ere due to cardiac causes in 19 of 43 patients (44%). Major
leeding was the cause of death in 21% (5 of 24) of the
oncardiac causes.
iscussion
perative risk in severe AS associated with LV dysfunction
s known to be increased, particularly when mean transval-
ular gradient is low. This retrospective multicenter study,
9 Era and the 2000 to 2005
1990 to 1999 Era and the 2000 to 2005 Era
o 1999 Era
112)
2000 to 2005 Era
(n  105) p Value
 8 71 8 0.28
(77%) 82 (78%) 0.82
(17%) 18 (17%) 0.95
(86%) 84 (80%) 0.26
(94%) 90 (86%) 0.05
 2.5 9.2 2.9 0.91
(22%) 29 (27%) 0.64
(21%) 34 (32%) 0.07
(18%) 29 (28%) 0.09
(29%) 29 (28%) 0.78
 0.15 0.71 0.15 0.69
 6 28 5 0.99
 5 26 5 0.32
(18%) 16 (15%) 0.60
 14 48 14 0.99
(27%) 33 (31%) 0.31
 2 23 2 0.71
(39%) 35 (33%)
(60%) 70 (67%) 0.41
(1%) 0
(41%) 37 (35%) 0.38
(36%) 35 (33%) 0.75
(8%) 18 (17%) 0.04
 62 98 48 0.07
 35 69 33 0.18
(21/23) 55% (6/11) 0.024
(20%) 10 (10%) 0.04
udy; †pre-operative NYHA functional status under medical treatment.199
the
990 t
(n 
72
86
19
96
105
8.9
25
24
20
32
0.72
28
25
20
47
30
23
44
68
1
46
40
9
113
76
91%
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Prognosis in Low-Gradient AS April 15, 2008:1466–72ur knowledge, shows that operative mortality decreased
rom 20% to 10% over recent years. The presence of
ultivessel CAD, MG, and DSE results were identified as
ndependent pre-operative predictors of perioperative mor-
ality. Moreover, we found that pre-operative standard
uroSCORE was a useful tool for operative risk stratifica-
ion. Long-term survival continued to be influenced by
re-operative MG, EuroSCORE, associated MVD, and
trial fibrillation.
Perioperative mortality (16%) in our series can be con-
idered to be acceptable, as rates ranging from 11% to 21%
ave been reported in previous studies on patients with
F/LGAS (3,8). Pereira et al. (7) recently reported a lower
perative mortality of 6% in a series of 68 patients. System-
tic echocardiography in the setting of congestive heart
ailure might bring earlier diagnosis of significant AS before
atients go into cardiogenic shock. Our study shows that
perative mortality decreased dramatically from 20% to 10%
n the recent era. This may be related to recent progress in
ardiac surgery and perioperative care, leading to a lower
ncidence of left ventricular failure during the perioperative
eriod. Moreover, the prevalence of cardiogenic shock as a
ause of death was lower in the more recent period of our
tudy. Perioperative risk can be clearly stratified. In our
tudy, a EuroSCORE10 identified a high-risk population
f patients with a perioperative mortality of 25%, compared
ith 12% for a EuroSCORE 10. Connolly et al. (3)
Predictors of Overall Mortality onUnivariate Analysis in the 217 Patients in the S
Table 3 Predictors of Overall Mortality onUnivariate Analysis in the 217 Patie
A
Age (yrs)
Men
Angina
Pre-operative NYHA functional class I to II*
History of congestive heart failure
EuroSCORE
Diabetes
Atrial fibrillation
Prior myocardial infarction
Multivessel coronary artery disease
Aortic valve area (cm2)
Left ventricular ejection fraction (%)
Mean transvalvular gradient (mm Hg)
Mean transvalvular gradient 20 mm Hg
Systolic pulmonary artery pressure (mm Hg)
Left bundle-branch block
Aortic prosthesis size (mm)
Aortic prosthesis type
Mechanical
Bioprosthesis
Aortic valve repair
Coronary artery bypass graft
Emergency AVR
*Pre-operative NYHA functional status under medical treatment.
Abbreviations as in Table 1.dentified small prosthesis size as the only predictor of (ospital mortality. In our study, we found that lower MG
nd presence of MVD were strong independent predictors
f perioperative mortality. Moreover, Connolly et al. (3)
eported a trend toward lower overall 5-year survival in
atients with associated CAD compared to patients without
AD in a series of 52 patients. Our larger study demon-
trated the major influence of MVD on operative mortality
nd long-term overall survival. Thus, in our series, the
-year survival rate was 37% in patients with associated
VD, compared with 55% in patients without associated
VD (p  0.02). Similarly, dobutamine stress hemody-
amic results are a strong predictor of perioperative mor-
ality in low-flow and very low-gradient AS (10). Pre-
perative atrial fibrillation was found to influence overall
urvival, reflecting long-standing disease, which may be
ssociated with more severe disease (16). In contrast, neither
rior myocardial infarction nor small prosthesis size, as
reviously reported by others (3,17), were predictors of
erioperative mortality in this study.
An improvement of functional class is frequently ob-
erved after AVR: 88% of patients in the series by Connolly
t al. (2) and 76% of our patients improved their NYHA
unctional class by more than 1 class. As previously de-
cribed (2,3,7,18), EF significantly improved after AVR
wing to afterload mismatch correction (19). The 49%
-year survival after AVR in our series was relatively high,
ompared with the 40% survival reported by Connolly et al.
in the Study
 129) Dead (n  88) p Value
8 72 8 0.24
7%) 69 (78%) 0.77
9%) 13 (14%) 0.46
9%) 12 (15%) 0.27
0%) 79 (90%) 0.97
5 9.7 5 0.0001
9%) 29 (33%) 0.03
3%) 28 (32%) 0.049
0%) 23 (26%) 0.40
2%) 33 (38%) 0.005
0.14 0.72 0.16 0.98
5 27 6 0.06
4 24 6 0.01
1%) 22 (25%) 0.006
13 47 14 0.87
2%) 21 (24%) 0.22
2 23 2 0.60
9.5%) 28 (32%)
0.26
0.5%) 59 (67%)
1 (1%)
0%) 35 (40%) 0.15
1%) 13 (15%) 0.39tudy
nts
live (n
71
99 (7
24 (1
25 (1
116 (9
8.3
25 (1
30 (2
26 (2
28 (2
0.72
28
26
14 (1
48
41 (3
23
51 (3
78 (6
0
39 (3
14 (13), including patients with a higher prevalence of CAD.
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April 15, 2008:1466–72 Prognosis in Low-Gradient ASore than one-half of late deaths in the present study were
ue to noncardiac causes. Thus, in LF/LGAS, significant
AD and very lowMG (20 mmHg) are 2 major risk factors
nfluencing both perioperative and long-term outcome.
tudy limitations. This study was retrospective, but it
ncluded consecutive patients operated for LF/LGAS, ac-
ording to the definition of American College of Cardiol-
gy/American Heart Association guidelines, in 11 Euro-
ean centers. The strength of this study is the large number
f patients included in different centers, giving statistical
ower and avoiding single-center biases. No larger series of
his type of patient has been published to date. Multivariate
nalyses in our study evaluated a relatively large number of
otential predictors relative to the number of events. In view
f the long inclusion period and the large number of centers,
nly 38% of patients in the study had DSE. As previously
eported (9,10), the strong prognostic value of contractile
eserve to assess the operative risk was demonstrated in this
ubgroup of patients. A more frequent use of DSE to
tratify operative risk over recent years in our study might
ave been an explanation for the decrease in operative
Figure 2 5-Year Overall Survival Curves
(A) Patients with and without prior atrial fibrillation, (B) patients with and without
mm Hg, and (D) patients with pre-operative European System for Cardiac Operativ
nary artery disease.ortality in the recent period. However, the percentage of satients who had DSE was not significantly different during
he 2 periods (35% in the 1990 to 1999 period vs. 41% in the
000 to 2005 period; p  0.38), similar to the proportion of
atients without contractile reserve during DSE (11% in the
990 to 1999 period vs. 10% in the 2000 to 2005 period;
 0.48). We cannot assess in our series the prognosis of
pseudosevere AS,” in which increase of transvalvular flow
esults in an increase in valve area to a nonsevere range (5),
s patients who had this response to DSE were not referred
or surgery in the different participating centers. However,
e cannot exclude the probability that some patients of our
eries may not have had critical AS. Pre-operative NYHA
unctional status in our study was evaluated under optimal
edical treatment. Seventeen percent (n  37) of our
atients were in pre-operative NYHA functional class II (no
atients were in class I). Actually, pre-operative NYHA
unctional status was evaluated under optimal medical
reatment (at least diuretics), and 90% of these 37 patients
n pre-operative NYHA functional class II had a recent
istory of congestive heart failure. The prevalence of pre-
perative NYHA functional classes I and II was 35% in the
ssel coronary artery disease, (C) patients with mean gradient 20 and 20
Evaluation score 10 and 10. AF  atrial fibrillation; MVD  multivessel coro-multive
e Riskeries reported by Pereira et al. (7) and 15% in the series of
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Prognosis in Low-Gradient AS April 15, 2008:1466–72onnolly et al. (3) and Powell et al. (17). Moreover, the
revalence of associated MVD in patients with less than
re-operative NYHA functional class III symptoms and in
atients in NYHA functional class III or IV was comparable
30% vs. 28%, p  0.79). Additionally, information on the
ecurrence of congestive heart failure after AVR was not
vailable. These data would have been useful to assess the
mprovement of quality of life after AVR.
onclusions
ne of the main findings of this European multicenter
tudy is a decrease in operative mortality over recent years in
atients with LF/LGAS. Operative risk is now acceptable
i.e., around 10%) and may be stratified by taking into
ccount the presence or absence of contractile reserve on
SE, presence of multivessel CAD, the value of pre-
perative MG, and EuroSCORE. Finally, in view of the
ery poor prognosis of unoperated LF/LGAS, the current
perative risk, and long-term outcome of operated patients,
ortic valve replacement is the treatment of choice in the
arge majority of cases of LF/LGAS.
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